Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Neutrophil and Lymphocyte Counts as Clinical Markers for Stratifying Low-Risk Prostate Cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Neutrophil and Lymphocyte Counts as Clinical Markers for Stratifying Low-Risk Prostate Cancer.
Neutrophil and Lymphocyte Counts as Clinical Markers for Stratifying Low-Risk Prostate Cancer. Clin Genitourin Cancer. 2016 Feb; 14(1):e1-8.
View in:
PubMed
subject areas
Disease-Free Survival
Humans
Kallikreins
Kaplan-Meier Estimate
Lymphocyte Count
Male
Middle Aged
Multivariate Analysis
Neoplasm Recurrence, Local
Neutrophils
Prostate-Specific Antigen
Prostatic Neoplasms
authors with profiles
Parth Modi